TY - JOUR
T1 - Abdominal mesh sacrocolpopexy for recurrent triple-compartment pelvic organ prolapse
AU - Gilleran, Jason P.
AU - Zimmern, Philippe
N1 - Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.
PY - 2009/4
Y1 - 2009/4
N2 - Objective To report the short- and intermediate- term outcome of safety and efficacy after abdominal-mesh sacrocolpopexy (MSC) for recurrent anterior, posterior and vault ('triple-compartment') pelvic organ prolapse (POP). Patients and methods In a database review we identified non-neurogenic women who had MSC for recurrent triple-compartment POP and with a ≥6-month cystographic follow-up. The preoperative evaluation included a history, physical examination, Urogenital Distress Inventory (UDI-6) and visual analogue quality-of-life (QoL) questionnaires, urodynamic studies, and a standing lateral voiding cysto-urethrogram (VCUG) with rest-strain views. All surgery as performed by the same surgeon, using polypropylene (Marlex) mesh. Perioperative data, the VCUG at 6 months, and interval pelvic examinations were recorded. RESULTS Between 2000 and 2006, 29 postmenopausal women (Caucasian, mean age 64 years, sd 11) underwent MSC. The mean (sd, range) operative duration was 228 (75, 170-340) min, the estimated blood loss 150 (100) mL and the inpatient stay 3 (1) days. At a mean (sd) follow-up of 23 (16) months, the physical examination showed no evidence of POP of grade ≥2, with mean POP-Quantification scores of -2.8 (0.4), -2.9 (0.4) and -9.3 (0.8) for points A a, A p and C, respectively. Two patients (8%) had evidence of grade ≥2 cystocele at the 6-month VCUG. After MSC, four of the six UDI and the QoL scores were significantly lower at the last follow-up than at baseline, with no change in sexual or defecatory function. CONCLUSIONS The Objective and subjective improvement at the short and intermediate follow-up after MSC suggest that this is a safe and effective treatment for recurrent triple-compartment POP.
AB - Objective To report the short- and intermediate- term outcome of safety and efficacy after abdominal-mesh sacrocolpopexy (MSC) for recurrent anterior, posterior and vault ('triple-compartment') pelvic organ prolapse (POP). Patients and methods In a database review we identified non-neurogenic women who had MSC for recurrent triple-compartment POP and with a ≥6-month cystographic follow-up. The preoperative evaluation included a history, physical examination, Urogenital Distress Inventory (UDI-6) and visual analogue quality-of-life (QoL) questionnaires, urodynamic studies, and a standing lateral voiding cysto-urethrogram (VCUG) with rest-strain views. All surgery as performed by the same surgeon, using polypropylene (Marlex) mesh. Perioperative data, the VCUG at 6 months, and interval pelvic examinations were recorded. RESULTS Between 2000 and 2006, 29 postmenopausal women (Caucasian, mean age 64 years, sd 11) underwent MSC. The mean (sd, range) operative duration was 228 (75, 170-340) min, the estimated blood loss 150 (100) mL and the inpatient stay 3 (1) days. At a mean (sd) follow-up of 23 (16) months, the physical examination showed no evidence of POP of grade ≥2, with mean POP-Quantification scores of -2.8 (0.4), -2.9 (0.4) and -9.3 (0.8) for points A a, A p and C, respectively. Two patients (8%) had evidence of grade ≥2 cystocele at the 6-month VCUG. After MSC, four of the six UDI and the QoL scores were significantly lower at the last follow-up than at baseline, with no change in sexual or defecatory function. CONCLUSIONS The Objective and subjective improvement at the short and intermediate follow-up after MSC suggest that this is a safe and effective treatment for recurrent triple-compartment POP.
KW - Cystocele
KW - Mesh sacrocolpopexy
KW - Pelvic prolapse
KW - Recurrence
UR - http://www.scopus.com/inward/record.url?scp=63449111846&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=63449111846&partnerID=8YFLogxK
U2 - 10.1111/j.1464-410X.2008.08296.x
DO - 10.1111/j.1464-410X.2008.08296.x
M3 - Article
C2 - 19154495
AN - SCOPUS:63449111846
SN - 1464-4096
VL - 103
SP - 1090
EP - 1094
JO - BJU international
JF - BJU international
IS - 8
ER -